These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 16483032)

  • 21. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National advisory committee on immunization (NACI). Statement on hepatitis B vaccine.
    Can Commun Dis Rep; 1993 Jul; 19(14):104-15. PubMed ID: 8364441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of circadian rhythm on the efficacy of the hepatitis B vaccination.
    Karabay O; Temel A; Koker AG; Tokel M; Ceyhan M; Kocoglu E
    Vaccine; 2008 Feb; 26(9):1143-4. PubMed ID: 18255201
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccines for neonatal viral infections: hepatitis B vaccine.
    Cutts FT; Hall AJ
    Expert Rev Vaccines; 2004 Aug; 3(4):349-52. PubMed ID: 15270632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B vaccine boosters: further studies in children.
    Milne A; Waldon J; Moyes CD; Pearce NE
    N Z Med J; 1990 Nov; 103(901):539-41. PubMed ID: 2147053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HBV serological markers of vaccinated children in remote areas of Taiwan: emphasis on factors contributing to vaccine failure.
    Huang ML; Liao WL; Ho MS
    Vaccine; 2007 Aug; 25(34):6326-33. PubMed ID: 17629600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Persistence of immunity after hepatitis B vaccination].
    Madaliński K
    Przegl Epidemiol; 2002; 56(4):605-13. PubMed ID: 12666586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The immunogenicity of the Heberbiovac-HB vaccine in children].
    Díaz González M; Chiang Macía A; Díaz Acosta D; Bravo González JR; Rodríguez Lay L; Pedroso Flaquet P; López-Chávez AU
    Rev Cubana Med Trop; 1996; 48(3):195-8. PubMed ID: 9805051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatitis B vaccine.
    John TJ
    Indian Pediatr; 1995 Jun; 32(6):715-8. PubMed ID: 8613350
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals.
    Da Villa G; Romanò L; Sepe A; Iorio R; Paribello N; Zappa A; Zanetti AR
    Vaccine; 2007 Apr; 25(16):3133-6. PubMed ID: 17280750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroepidemiology of hepatitis B in Greek children 6 years after the implementation of universal vaccination.
    Papaevangelou V; Hadjichristodoulou C; Cassimos DC; Pantelaki K; Tzivaras A; Hatzimichael A; Theodoridou M
    Infection; 2008 Mar; 36(2):135-9. PubMed ID: 18231718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hepatitis B: the incidence of carriers and the initial experience of mass vaccination in the police].
    Cioli S; Cordelli A; Sardone D; Giannelli G; Lalli CG; Maresca A; Pioda GB; Lanzetta BM; D'Annibali E
    G Ital Med Lav; 1990; 12(2-4):81-5; discussion 85-6. PubMed ID: 2152608
    [No Abstract]   [Full Text] [Related]  

  • 37. Statement on hepatitis B vaccine. National Advisory Committee on Immunization.
    CMAJ; 1993 Nov; 149(10):1465-80. PubMed ID: 8221430
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunosurveillance of transfusion dependent thalassaemia and hepatitis B vaccination.
    Mazumder M; Sengupta B; De M; Lahiri P; Bhattacharya DK
    J Assoc Physicians India; 1993 Jun; 41(6):342-4. PubMed ID: 8005968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B vaccination: to boost or not to boost?
    Kao JH; Chen DS
    Lancet; 2005 Oct 15-21; 366(9494):1337-8. PubMed ID: 16226597
    [No Abstract]   [Full Text] [Related]  

  • 40. The recombinant hepatitis B surface antigen vaccine in persons with HIV: is seroconversion sufficient for long-term protection?
    Powis JE; Raboud J; Ostrowski M; Loutfy MR; Kovacs C; Walmsley SL
    J Infect Dis; 2012 May; 205(10):1534-8. PubMed ID: 22448009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.